Importance of immune response in tumour kill – the allogeneic graft-versus-tumour effect.

 The difference the cell source makes – the changes that using mobilised peripheral blood cells for transplant have brought to the field : infrastructure, safety, costs, survival, tumour kill.

 The graft is more than the erythrocytes, neutrophils and platelets – lymphocytes/NK cells, dendritic cells, mesenchymal stromal cells.

 Minimal residual disease – predictor or treatment stratifier?